Filing Details
- Accession Number:
- 0001140361-15-001483
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-12 18:22:34
- Reporting Period:
- 2015-01-08
- Filing Date:
- 2015-01-12
- Accepted Time:
- 2015-01-12 18:22:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1228627 | Rexahn Pharmaceuticals Inc. | RNN | Pharmaceutical Preparations (2834) | 113516358 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317190 | Heum Tae Jeong | C/O Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville MD 20850 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-08 | 78,782 | $0.80 | 583,782 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-08 | 78,782 | $0.90 | 505,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-09 | 188,690 | $0.80 | 693,690 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-09 | 188,690 | $0.92 | 505,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-12 | 49,800 | $0.80 | 554,800 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-12 | 49,800 | $0.91 | 505,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to purchase) | Disposition | 2015-01-08 | 78,782 | $0.00 | 78,782 | $0.80 |
| Common Stock | Stock Option (right to purchase) | Disposition | 2015-01-09 | 188,690 | $0.00 | 188,690 | $0.80 |
| Common Stock | Stock Option (right to purchase) | Disposition | 2015-01-12 | 49,800 | $0.00 | 49,800 | $0.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 421,218 | 2015-01-20 | No | 4 | M | Direct | |
| 232,528 | 2015-01-20 | No | 4 | M | Direct | |
| 182,728 | 2015-01-20 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price of $0.9004 per share represents a weighted average of sales prices from $0.90 to $0.9088 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price of $0.9153 per share represents a weighted average of sales prices from $0.90 to $0.945 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price of $0.9135 per share represents a weighted average of sales prices from $0.90 to $0.9325 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Options vested and became exercisable based on the following schedule: 150,000 on January 20, 2006, 150,000 on January 20, 2007, and 200,000 on January 20, 2008.
Billionaire Hedge Funds
